Gaviscon makers deny bid to monopolise market

The makers of indigestion medicine Gaviscon today denied attempting to maintain a market monopoly, thereby “cheating the NHS” out of millions of pounds, after a series of emails were leaked.

Executives at Reckitt Benckiser created obstacles to rival products, the emails suggested.